UBS Group
MOR

UBS Group’s MorphoSys AG American Depositary Shares MOR Stock Holding History

UBS Group’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-35,900
Closed -$653K – 10428
2024
Q2 		$653K Hold
35,900
– – ﹤0.01% 4791
2024
Q1 		$651K Buy
+35,900
New +$531K ﹤0.01% 4982

Other funds holding MOR

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group's MOR Position: Q3 2024 in Review

UBS Group sold out of MorphoSys AG American Depositary Shares (MOR) in Q3 2024, closing a stake of 3,317 shares — an estimated $60.4K sold.

UBS Group first reported a position in MOR in Q2 2018 and held it in 23 quarters. The position peaked at $21.2M in Q1 2024. 9 funds tracked by Wall St. Rank hold MOR as of Q3 2024.

  • UBS Group reported no remaining MorphoSys AG American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 3,317 MorphoSys AG American Depositary Shares shares in Q3 2024, an estimated $60.4K.
  • UBS Group first reported a position in MorphoSys AG American Depositary Shares in Q2 2018 and held it in 23 quarters.
  • UBS Group's MorphoSys AG American Depositary Shares position peaked at $21.2M in Q1 2024.
  • 9 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.